>
pdufa.bio

MBX 2109

Updated ยทnext FDA decision on the calendar

MBX 2109 is a MBX Biosciences, Inc. program. Its next catalyst is a Readout in May 2027. Every date links its source.

MBX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: MBX Biosciences, Inc. (MBX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · May 2027MBX

Questions

When is MBX 2109's next FDA decision or readout?

The next tracked catalyst for MBX 2109 is a Readout in May 2027.

What happened at MBX 2109's most recent FDA decision?

No FDA decision for MBX 2109 is in our archive yet.

Who makes MBX 2109?

MBX Biosciences, Inc. (MBX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.